Vanda Pharmaceuticals (VNDA) Tops Q4 Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Vanda Pharmaceuticals (VNDA) Tops Q4 Views

Vanda Pharmaceuticals (VNDA) PT Lowered to $21 at Oppenheimer

February 14, 2019 8:10 AM EST

Oppenheimer analyst Esther Rajavelu lowered the price target on Vanda Pharmaceuticals (NASDAQ: VNDA) to $21.00 (from $29.00) while maintaining a Perform rating.

The analyst commented, "VNDA reported 4Q results that were higher than our estimates and provided 2019 guidance which came in below our (and... More